Immediate Impact

66 standout
Sub-graph 1 of 21

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
2 intermediate papers

Works of Assaf Issachar being referenced

Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease
2018

Author Peers

Author Last Decade Papers Cites
Assaf Issachar 261 283 126 138 27 596
Orhan Kürşat Poyrazoğlu 173 331 172 62 31 707
Signe Wiese 446 390 175 176 31 606
Raymond Sayegh 324 339 188 51 33 537
Jörg Arend 263 207 162 74 28 627
John H. Helzberg 203 218 198 108 32 575
Süleyman Uraz 188 254 227 59 30 616
Ömer Şentürk 130 345 162 115 43 624
Chiao‐Lin Chuang 169 182 113 76 43 517
Nikolaos Eugenidis 152 196 290 88 32 538
Matthias Hoke 127 208 146 161 30 640

All Works

Loading papers...

Rankless by CCL
2026